The Global Lung Cancer Coalition is the international 'voice' of lung cancer patients

The Global Lung Cancer Coalition (GLCC) promotes global understanding of the burden of lung cancer and the right of patients to effective early detection, better treatment and supportive care. We are committed to improving disease outcomes for all.

Established in 2001, the GLCC is composed of non-government patient organisations from Argentina, Australia, Bulgaria, Canada, Denmark, Egypt, France, Germany, Ireland, Italy, Japan, Netherlands, Norway, Portugal, Slovenia, Spain, Sweden, Switzerland, UK and US.

The GLCC aims to address the following issues:

  • place lung cancer on the global healthcare agenda
  • change public perceptions and lessen the stigma of lung cancer
  • empower lung cancer patients to take an active role in their care
  • effect change in legislative or regulatory policies to optimise treatment and care

November is Lung Cancer Awareness Month

Lung Cancer Awareness Month takes place every November.

It aims to achieve better outcomes for lung cancer patients and their families through:

  • raising public awareness of lung cancer
  • educating those at risk about symptoms and early presentation
  • signposting sources of information and support
  • placing lung cancer firmly on the agenda of healthcare authorities

Late stage diagnosis, poor survival outcomes and few treatment choices make lung cancer a particularly devastating and emotional disease for people to deal with.

There are many negative perceptions and stigmas surrounding the disease, which indirectly impact on funding, resources and how individuals view the condition.

Click here to view our members' websites and find out what is happening in your country this November.

Click here to download our lung cancer awareness leaflets.

Global Perceptions of Lung Cancer

Lung cancer patients are likely to suffer significant stigma due to the disease's link to smoking, according to a survey published by the GLCC. Dr Matthew Peters, chair of the Global Lung Cancer Coalition, said:

"This research carried out by Ipsos Mori on behalf of GLCC supports what we have suspected for a long time; that lung cancer carries a noteworthy stigma.

Although the majority of those questioned rejected the notion that they felt less sympathetic towards lung cancer sufferers because of its association with smoking, there was still a significant proportion who admitted they did stigmatise the disease.

You simply do not see this type of blame culture with any other cancer.

Lung cancer is the biggest cancer killer in the world and we need to increase public sympathy for the disease, not just on behalf of the patients but also in order to secure vital funding for research into this truly awful disease. Whether they have smoked or not, no one deserves lung cancer."

 

 


Syndicate content